Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
1999 (Pharm Res) Type Phase I PK/PD Subjects 40 healthy male volunteers Key Finding Dose-proportional pharmacokinetics
Other companies are exploring different combinations of hormone agonists, different dosing strategies, and oral formulations of dual agonists
The Eli Lilly lawsuits Eli Lilly has been aggressive in protecting its tirzepatide market
a complete cAMPPKA mechanism
A web-based integrative transcriptome analysis, RNAseqChef, uncovers the cell/tissue type-dependent action of Sulforaphane
US$ 29.75
US$ 22.30
US$ 22.53
US$ 21.29
US$ 25.13
